Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Featured Stories

Advocates Ask Medicare To Reverse Transplant Patient Test Payment Policy

A recent Capitol Hill event drew speakers such as Newt Gingrich, Sen. Kirsten Gillibrand, and musician Al B. Sure to protest a Medicare contractor’s decision to restrict coverage of blood tests used to detect early signs of rejection or organ damage in transplant patients.

Policy Lobbying Medicare

Medtronic Is Not Going With The EOFlow – Deal Cancelled

Medtronic is dropping plans to acquire EOFlow, which has faced numerous patent lawsuits from Insulet.

M & A Diabetic Care Deals

23andMe Data Breach Larger Than Previously Reported

The numbers for the genetic testing company’s October data breach are much larger than previously reported, and now the company might be trying to shield itself from class action lawsuits. 

Cybersecurity Medical Device In Vitro Diagnostics

Edwards Plans To Boost Growth By Spinning Off Critical Care Unit In 2024

The critical care business is developing smart-recovery products integrated into Edwards’ HemoSphere monitoring platform. The company expects the tax-free transaction will help the new company advance patient monitoring technology and let Edwards focus on its structural heart technologies.

M & A Patient Monitoring Cardiovascular

Spotlight On Medtech Meetings

Israeli Medtech Leaders Say War Is Impacting Companies, Driving Industry Humanitarian Effort

Two executives of Israeli-based medtech companies say the Hamas-Israeli war is having an impact on their companies, with employees being called up as reservists and others needing accommodations. It also has galvanized companies to join forces to support health and humanitarian needs during the crisis.

Israel Artificial Intelligence

Medtech Insight Podcasts


This Episode:

 Medtech Connect Episode 10: Breaking Down The Transitional Coverage Of Emerging Technologies
 

Listen to Medtech Insight podcasts for our perspectives on regulation, policy, quality, R&D and key commercial topics.

More Podcasts

Global Device Regulation

Opinion: At Least It’s Not Fruitcake – My Annual FDA Predictions

Consultant (and former FDAer) Steve Silverman is back with a reflection on his predictions for 2023, and well as what he expects to see in the coming year. 

Regulation Compliance

EU Lists Its First Reference Laboratories For High-Risk IVDs Falling Into Class D

There are 10 listings in the first  group of EU reference laboratory to be named. They will not formally assess IVDs for about a year and even then only evaluate products that are in a later batch to comply with the IVD Regulation.

Europe EU

German Medtechs Search For Blue Skies Amid ‘Cloudy Outlook’ For Industry − Medica 2023

While revenues are looking healthier at last, a host of issues in the post-COVID readjustment phase still weigh heavily on medtech manufacturers in Germany, chief among which is EU and national over-regulation. Hospital reform and the digital shift are also on a long list of priority issues to monitor and tackle if Germany’s industrial base is to remain preeminent, said BVMed chief executive Marc-Pierre Möll.

Germany Policy

Mosie Baby First To Win FDA Clearance For At-Home Artificial Insemination Kit

Austin-based start-up Mosie received FDA clearance for a home insemination kit to help people get pregnant. The kit retails for $129.99.

Women's Health Approvals
Digital Health

Opinion: At Least It’s Not Fruitcake – My Annual FDA Predictions

Consultant (and former FDAer) Steve Silverman is back with a reflection on his predictions for 2023, and well as what he expects to see in the coming year. 

Regulation Compliance

MDR Changes Aren’t A ‘Catalyst’ For Medtech Investments In Ireland

IDA Ireland’s Rachel Shelly tells Medtech Insight about what is (and isn’t) driving investment in medtech. 

Digital Health Regulation

‘One Little Cog’: Former J&J Attorney Discusses Return To Private Practice

In this wide-ranging interview, lawyer Philip Desjardins talks about regulatory issues from AI to LDTs – as well as the passion for patient health that keeps him in the medtech arena.

Policy Regulation

AMA Establishes Principles For ‘Augmented Intelligence’

The American Medical Association has written a set of principles for augmented intelligence (AI) development and deployment in health care. The organization hopes these principles can shape “a consistent governance structure for advancements in health care technology.”

Artificial Intelligence Government Payers
See All
Interviews

Q&A: The “Secret Sauce” Of Sofinnova’s New AI-Based Investment Platform

The venture group has debuted Sofinova.AI, a software platform capable of viewing a potential investment in much more detail than a human.

Artificial Intelligence Deals

German Medtechs Search For Blue Skies Amid ‘Cloudy Outlook’ For Industry − Medica 2023

While revenues are looking healthier at last, a host of issues in the post-COVID readjustment phase still weigh heavily on medtech manufacturers in Germany, chief among which is EU and national over-regulation. Hospital reform and the digital shift are also on a long list of priority issues to monitor and tackle if Germany’s industrial base is to remain preeminent, said BVMed chief executive Marc-Pierre Möll.

Germany Policy

“We’re A Pain-Management Company.” Nevro Adds SI Joint Surgery To SCS Business

Nevro is known for its spinal cord stimulation technology but wants to help a wide range of patients with chronic pain, so it is buying Vyrsa, which offers a complete system for sacroiliac joint fusion. In and interview with Medtech Insight, Nevro CEO Kevin Thornal explained how  Vyrsa supports Nevro's strategy in this growing market.

Exec Chats M & A

MDR Changes Aren’t A ‘Catalyst’ For Medtech Investments In Ireland

IDA Ireland’s Rachel Shelly tells Medtech Insight about what is (and isn’t) driving investment in medtech. 

Digital Health Regulation
Podcasts

Digital Health Roundup: Black Friday Hits – Digital Twins, Biowearables, Robotics, Cardiology

In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights interviews with Abbott’s head of Lingo Biowearables and top executives at Twin Health. Reed Miller provides an update on J&J MedTech’s launch of the Ottava soft-tissue robotic surgery system and Barnaby Pickering talks about his recent interview with Leo Grady, former CEO of Paige AI, to talk about his new start-up Jona.

Digital Health Approvals

Digital Health Roundup: HLTH, LSX, AdvaMed; FDA And Pre-Determined Change Control Plans

In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights interviews with behavioral health experts on implementing AI solutions to help ease the administrative burden on clinicians as well as recent coverage from the LSX Congress USA and HLTH conferences. Reed Miller discusses findings of EY’s annual pulse of the medtech industry report and Hannah Daniel discusses FDA guidance on regulating AI/ML.

Artificial Intelligence Behavioral Health

Podcast: The Realities Of Real-World Evidence

In this special podcast, Medtech Insight managing editor Elizabeth Orr talks to consultant Steve Silverman about the FDA’s current position on real-world evidence and real-world data, as well as how manufacturers can best put the evidence types to use.

Policy Real-World Evidence

Medtech Connect Episode 10: Breaking Down The Transitional Coverage Of Emerging Technologies

In this episode, Medtech Insight regulatory reporter Hannah Daniel speaks to Washington Analysis vice president and senior healthcare analyst John Leppard about the Center for Medicare and Medicaid’s Transitional Coverage Of Emerging Technologies pathway, or TCET. He breaks down the pathway and discusses its pros and cons, as well as potential next steps for the agency. We also explore the history of breakthrough device coverage as well as the challenges for coverage of digital health devices.

Medicare Regulation
See All
Recent Stories

Opinion: At Least It’s Not Fruitcake – My Annual FDA Predictions

Consultant (and former FDAer) Steve Silverman is back with a reflection on his predictions for 2023, and well as what he expects to see in the coming year. 

Regulation Compliance

Q&A: The “Secret Sauce” Of Sofinnova’s New AI-Based Investment Platform

The venture group has debuted Sofinova.AI, a software platform capable of viewing a potential investment in much more detail than a human.

Artificial Intelligence Deals

EU Lists Its First Reference Laboratories For High-Risk IVDs Falling Into Class D

There are 10 listings in the first  group of EU reference laboratory to be named. They will not formally assess IVDs for about a year and even then only evaluate products that are in a later batch to comply with the IVD Regulation.

Europe EU

German Medtechs Search For Blue Skies Amid ‘Cloudy Outlook’ For Industry − Medica 2023

While revenues are looking healthier at last, a host of issues in the post-COVID readjustment phase still weigh heavily on medtech manufacturers in Germany, chief among which is EU and national over-regulation. Hospital reform and the digital shift are also on a long list of priority issues to monitor and tackle if Germany’s industrial base is to remain preeminent, said BVMed chief executive Marc-Pierre Möll.

Germany Policy

Mosie Baby First To Win FDA Clearance For At-Home Artificial Insemination Kit

Austin-based start-up Mosie received FDA clearance for a home insemination kit to help people get pregnant. The kit retails for $129.99.

Women's Health Approvals

“We’re A Pain-Management Company.” Nevro Adds SI Joint Surgery To SCS Business

Nevro is known for its spinal cord stimulation technology but wants to help a wide range of patients with chronic pain, so it is buying Vyrsa, which offers a complete system for sacroiliac joint fusion. In and interview with Medtech Insight, Nevro CEO Kevin Thornal explained how  Vyrsa supports Nevro's strategy in this growing market.

Exec Chats M & A

MDR Changes Aren’t A ‘Catalyst’ For Medtech Investments In Ireland

IDA Ireland’s Rachel Shelly tells Medtech Insight about what is (and isn’t) driving investment in medtech. 

Digital Health Regulation

eSTAR Now Open For PMA Submissions

The US FDA electronic submission process for streamlining its product review process is now available for sponsors submitting some premarket approval applications.

FDA Policy

FDA Evaluating Safety Of Plastic Syringes From China, May Prevent Their Import To The US

The US FDA is advising the public that certain plastic syringes from China could fail, leak, or break. If necessary, the agency may prevent Chinese syringes from entering the US.

FDA Manufacturing

Global Medtech Guidance Tracker: November 2023

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Over 40 documents have been posted on the tracker since its last update.

Guidance Documents Regulation

European Health Data Space Regulation: Hurdles Ahead As Negotiations Intensify

As the European Health Data Space Regulation heads towards a more intense discussion phase, EU member states still have concerns over patient data autonomy, data storage, and resources for developing national health data platforms.

Medical Device Regulation

Seeing The Wood From The Shrubs: Azalea Begins Tests Of Its Smart Contact Lens

The Belgian start-up is developing a scleral contact lens with an inbuilt LCD screen capable of filtering light – offering a non-surgical solution to a variety of ophthalmic conditions.

Ophthalmology Clinical Trials
UsernamePublicRestriction

Register